Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: Clin Cancer Res. 2018 Apr 4;24(14):3299–3308. doi: 10.1158/1078-0432.CCR-17-3008

Table 2.

Contingency table evaluating the association between HDD and non-responsiveness to ipilimumab treatment. Two-tailed Fisher Exact test, P = 0.06, odds ratio (OR) = 2.79. HDD, homozygous deletion of defensin.

α-, β-DEFs
(Homozygous deletion)
α-, β-DEFs
(1 or more copies)
Total
Non-responder 22 50 72
Responder + Long-term survivor 5 32 37
Total 27 82 109